跳至主要内容
临床试验/NCT07140653
NCT07140653招募中4 期

Evaluation of Arcuate Incisions for Correcting Pre-Existing Corneal Astigmatism in Combination With the Light Adjustable Lens for Cataract and Refractive Lens Exchange Surgery

Center For Sight4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月2日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60
试验地点
4
主要终点
Number of LAL adjustments required to achieve the desired refraction

研究概览

简要总结

This study aims to evaluate the safety and effectiveness of femtosecond laser arcuate corneal relaxing incisions (AK) combined with Light Adjustable Lens (LAL) implantation for correcting pre-existing corneal astigmatism in patients undergoing cataract or refractive lens exchange surgery. Postoperative assessments will focus on residual refractive astigmatism, visual outcomes, patient satisfaction, and the incidence of adverse events. Arcuate keratotomy and toric IOLs are well-established methods for astigmatism correction, and this study will compare their combined effectiveness using advanced femtosecond laser technology.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must be aged ≥ 21 years at the time of eligibility visit.
  • Subject must have a vector difference of 0.50 D or less in magnitude of pre-operative anterior corneal astigmatism as measured by the Pentacam AXL and the Zeiss IOLMaster 700 (Carl Zeiss Meditec).
  • Subject must be able and willing to comply with the study examination procedures.
  • Astigmatic treatment must require paired arcs <45mm in length.
  • Subject must be willing to complete the approved informed consent form.
  • Subject must have elected to undergo lens extraction and Light Adjustable Lens (LAL) implantation.
  • Subject must be willing and able to return for scheduled pre-op and follow-up examinations.
  • Subject must have central 7 mm of clear cornea without vascularization.

排除标准

  • Subject who has undergone previous corneal or intraocular surgery in the eye to be treated.
  • Subject with a history, signs or symptoms of ocular disease or atypical findings that would be contraindicated under standard of care for lens extraction surgery.
  • Subject with neuro-ophthalmic disease.
  • Diabetic or hypertensive subject with clinical evidence of retinal pathology that the investigator believes will significantly affect visual outcomes.
  • Subject with macular degenerative pathology identified at the preoperative visit that the investigator believes will significantly affect visual outcomes.
  • Subject with a history of steroid-responsive rise in intraocular pressure (IOP), preoperative IOP >25 mmHg, or uncontrolled glaucoma in either eye.
  • Subject with known lens/zonular instability.
  • Subject who cannot achieve dilated pupillary diameter > 6 mm.
  • Subject with abnormal corneal topography, including evidence of forme fruste keratoconus, keratoconus or pellucid marginal degeneration.
  • Subject with posterior segment disease or degeneration.
  • Subject with corneal disease or pathology that precludes an adequate view for imaging or transmission of laser wavelength of light.
  • Subject with known sensitivity to planned perioperative standard of care medications.
  • Subject participating in any other ophthalmic drug or device clinical trial during the time of this clinical assessment.
  • Subject with known sensitivity to planned assessment concomitant medications.
  • Subjects with severe dry eye syndrome (DES) or history of ocular inflammation that may impact visual outcomes.
  • Subject with irregular astigmatism in the eye to be treated.

结局指标

主要结局

Number of LAL adjustments required to achieve the desired refraction

时间窗: 8 weeks after last lock-in

次要结局

  • Percentage of eyes with residual refractive astigmatism ≤ 0.50 D(8 weeks after last lock-in)

研究者

发起方
Center For Sight
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验